ICL trades 27.8% below Wall Street's consensus target of $5.98.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ICL achieves its forward estimates and maintains a stable P/E multiple of 11.5x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, ICL Group Ltd (ICL) has a Wall Street consensus price target of $5.98, based on estimates from 4 covering analysts. With the stock currently trading at $4.68, this represents a potential upside of +27.8%. The company has a market capitalization of $6.04B.
Analyst price targets range from a low of $5.45 to a high of $6.50, representing a 18% spread in expectations. The median target of $6.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, ICL trades at a trailing P/E of 19.8x and forward P/E of 11.5x. The forward PEG ratio of 0.20 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +72.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $9.21, with bear and bull scenarios of $5.80 and $12.13 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MOSThe Mosaic Company | $7.1B | $22.36 | $24.70 | +10.5% | Hold | 65.1x | 49 |
 NTRNutrien Ltd. | $34.3B | $71.48 | $75.17 | +5.2% | Buy | 14.7x | 33 |
 CFCF Industries Holdings, Inc. | $18.3B | $119.39 | $128.00 | +7.2% | Buy | 7.9x | 43 |
 SMGThe Scotts Miracle-Gro Company | $3.8B | $64.71 | $76.33 | +18.0% | Buy | 14.6x | 17 |
 IPIIntrepid Potash, Inc. | $442M | $32.90 | $34.50 | +4.9% | Hold | 15.3x | 27 |
 AVDAmerican Vanguard Corporation | $28M | $0.96 | $17.00 | +1665.9% | Buy | 2.5x | 13 |
 FMCFMC Corporation | $705M | $5.63 | $11.35 | +101.6% | Hold | — | 42 |
 ASXASE Technology Holding Co., Ltd. | $69.5B | $31.63 | — | — | Buy | 0.8x | 5 |
 DEDeere & Company | $181.3B | $671.65 | $731.20 | +8.9% | Buy | 37.2x | 46 |
 CTVACorteva, Inc. | $53.3B | $11.90 | $38.64 | +224.7% | Buy | 20.6x | 37 |
Quick answers to the most common questions about buying ICL stock.
The consensus Wall Street price target for ICL is $5.98, representing 27.8% upside from the current price of $4.68. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ICL has a consensus rating of "Hold" based on 4 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $5.98 implies 27.8% upside from current levels.
With a forward P/E of 11.4988x, ICL trades at a relatively low valuation. The consensus target of $5.98 implies 27.8% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $6.5 for ICL, while the most conservative target is $5.45. The consensus of $5.98 represents the median expectation. Our quantitative valuation model projects a bull case target of $12 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ICL is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ICL stock forecast based on 4 Wall Street analysts shows a consensus price target of $5.98, with estimates ranging from $5.45 (bear case) to $6.5 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $9, with bear/bull scenarios of $6/$12.
Our quantitative valuation model calculates ICL's fair value at $9 (base case), with a bear case of $6 and bull case of $12. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
ICL trades at a forward P/E ratio of 11.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 19.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on ICL, with a "Hold" consensus rating and $5.98 price target (27.8% upside). 0 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ICL analyst price targets range from $5.45 to $6.5, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $5.98 consensus represents the middle ground. Our model's $6-$12 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.